Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation in continuous renal replacement therapy.

S Abramson1, J L Niles

  • 1Renal Division, Brigham and Women's Hospital & Harvard Medical School, Boston, Massachusetts, USA.

Current Opinion in Nephrology and Hypertension
|January 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis.

Osteoarthritis and cartilage·2019
Same author

The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?

Annals of the rheumatic diseases·2013
Same author

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

Lancet (London, England)·2013
Same author

Four-quadrant optical matrix-vector multiplication machine as a neural-network processor.

Applied optics·2010
Same author

Constitutional factors in resistance to infection; the effect of estrogen on the pathogenesis of tuberculosis.

Federation proceedings·2010
Same author

Constitutional factors in resistance to infection; the effect of estrogen on the pathogenesis of tuberculosis.

Journal of bacteriology·2010
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

Continuous renal replacement therapies (CRRTs) are beneficial for acute renal failure patients but require anticoagulation. Citrate regional anticoagulation is preferred for CRRTs due to ease of use and reduced bleeding risk.

Area of Science:

  • Nephrology
  • Critical Care Medicine

Background:

  • Continuous renal replacement therapies (CRRTs) offer gradual solute/fluid removal, often better tolerated than hemodialysis in critically ill acute renal failure patients.
  • Anticoagulation is essential for CRRT filter patency but poses a significant bleeding risk in vulnerable patients.
  • Standard anticoagulation methods like low-dose heparin (10-50% bleeding risk) and regional anticoagulation with protamine (difficult to use) have limitations.

Purpose of the Study:

  • To evaluate regional citrate anticoagulation as a preferred anticoagulant for CRRTs.
  • To compare the efficacy and safety of citrate anticoagulation against other methods in CRRT.

Main Methods:

  • Review of existing literature on anticoagulation strategies for CRRT.
  • Analysis of clinical data comparing regional citrate anticoagulation with heparin, low molecular weight heparin, and prostacyclin.

Related Experiment Videos

  • Assessment of filter patency, bleeding complications, and ease of use for different anticoagulants.

    • Main Results:

    • Regional citrate anticoagulation is easy to administer and effectively maintains filter patency in CRRT.
    • Citrate anticoagulation significantly reduces systemic bleeding risks compared to unfractionated heparin.
    • Alternative anticoagulants like low molecular weight heparin and prostacyclin show partial benefits but present dosing challenges.

    Conclusions:

    • Regional citrate anticoagulation is the anticoagulant of choice for most patients undergoing CRRT.
    • Citrate offers a favorable balance of efficacy, safety, and usability for maintaining CRRT filter function.
    • Further research may explore optimal citrate dosing protocols and management in diverse patient populations.